Prelude Capital Management, LLC Teva Pharmaceutical Industries LTD Call Options Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $23,547 - $38,048	-2,900 Reduced 96.67%	100 $1,000
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $17,394 - $34,970	2,600 Added 650.0%	3,000 $27,000
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $1,306 - $2,144	200 Added 100.0%	400 $4,000
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $931,684 - $1.2 Million	-59,800 Reduced 99.67%	200 $3,000
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $1.26 Million - $1.54 Million	60,000 New	60,000 $1.29 Million

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.